AUTHORS

Dolores Albarracín, PhD — Alexandra Heyman Nash University Professor at the University of Pennsylvania — is an expert in communication and behavioral change. A social psychologist, she has studied communication and intervention effects in a number of contexts, including HIV, COVID-19, and vaccination.

Trevor Bedford, PhD
Professor, Vaccine and Infectious Disease, Human Biology and Public Health Sciences Divisions
Fred Hutchinson Cancer Research Center
Howard Hughes Medical Institute Investigator
Howard Hughes Medical Institute
Affiliate Associate Professor, Departments of Genome Sciences and Epidemiology
University of Washington

Thomas Bollyky, JD
Senior Fellow for Global Health, Economics, and Development
Director of the Global Health Program
Council on Foreign Relations

Luciana Borio, MD — Venture Partner at Arch Venture Partners and a Senior Fellow for Global Health, Council on Foreign Relations — is an infectious disease physician specializing in emerging infectious diseases, complex public health emergencies, and biodefense. She was a member of the Biden-Harris Transition COVID-19 Advisory Board. She previously served as the director for medical and biodefense preparedness policy at the National Security Council (2017-2019) and acting chief scientist, U.S. Food and Drug Administration (2015-2017).

Rick A. Bright, PhD — CEO, Pandemic Prevention Institute – is an immunologist and virologist who has led the development of multiple drugs, vaccines and diagnostics. He is the Chief Executive Officer of the Pandemic Prevention Institute and Senior Vice President of Pandemic Prevention and Response of The Rockefeller Foundation. He was the Director of the Biomedical Advanced Research and Development Authority (BARDA) and the Deputy Assistant Secretary for Preparedness and Response in the US Department of Health and Human Services. He was a member of the Biden-Harris Transition COVID-19 Advisory Board. He is a Senior Fellow of the Foreign Policy Association and serves on the Executive Board of the International Science Reserve.

Lisa M. Brosseau, ScD, CIH — Research Consultant, University of Minnesota, Center for Infectious Disease Research and Policy — is an industrial hygienist with more than 25 years of research expertise in respiratory protection for infectious and other hazardous aerosol exposures in workplaces.

Kizzmekia S. Corbett, PhD — Assistant Professor of Immunology and Infectious Diseases at Harvard T. H. Chan School — is a former team lead at the NIH Vaccine Research Center where she led coronavirus research efforts. She is most known for developing the Moderna COVID-19 vaccine.

R.P. Eddy, — CEO of Ergo—is a former Director at the White House National Security Council, senior U.S. and UN Diplomat and WHO / UNAIDS executive. An architect of the 1996 White House pandemic response plan NSTC-7 and the design of the Global Fund for HIV/AIDS, Tuberculosis and Malaria. Co-author of an award-winning book on decision making to forecast catastrophes (including pandemics) Warnings (2017).

Ezekiel J. Emanuel, MD, PhD — Vice Provost of Global Initiatives at the University of Pennsylvania — was a member of the Biden-Harris Transition COVID-19 Advisory Board, the founding chair of the Department of Bioethics at NIH, and a former White House health care advisor in the Obama Administration.

Howard Forman, MD, MBA - Professor of Public Health, Radiology, Management & Economics at Yale University — has developed health and health care management and leadership programs at Yale and Yale New Haven Hospital. During the pandemic, he has been an advocate for data transparency and workforce wellness initiatives.

Akiko Iwasaki, PhD — Sterling Professor of Immunobiology, Professor of Molecular, Cellular and Developmental Biology, Professor of Epidemiology (Microbial Diseases), Investigator, Howard Hughes Medical Institute, Yale School of Medicine — is an immunologist with expertise in immune protection and pathogenesis following viral infections at the mucosal surfaces. She leads multiple studies to interrogate the pathobiology of long COVID, both in patients and by developing animal models.

Jill Jim, PhD, MPH, MHA — Navajo Department of Health Executive Director — continues to address the ongoing COVID-19 public health emergency. She was also a member of the Biden Harris COVID-19 Advisory Board.

Terris King, ScD is the Principal of King Enterprise Group, transforming health care by lowering cost, increasing community engagement, promoting vaccine acceptance, and reducing inequities. Dr. King previously served as a Senior Executive for CMS where he established the Office of Minority Health as their first Director, Deputy Director of the Office of Clinical Standards and Quality, and retired as the Deputy CIO.

Harlan M. Krumholz, MD, SM
Harold H. Hines, Jr. Professor of Medicine (Cardiology)
Professor in the Institute for Social and Policy Studies
Director, Center for Outcomes Research and Evaluation (CORE)
Yale School of Medicine

David Michaels, PhD, MPH — Professor of Environmental and Occupational Health, Milken Institute School of Public Health, The George Washington University — served as Assistant Secretary of Labor for the Occupational Safety and Health Administration 2009-2017, and was the longest serving administrator in the agency’s history. He also was a member of the Biden Harris Transition Advisory Board.

Michael J. Mina, MD, PhD — Chief Science Officer at eMed — was a professor in Epidemiology, Immunology and Infectious Diseases at Harvard T.H. Chan School of Public Health and associate director of Molecular Virology at Brigham and Women’s Hospital, Harvard Medical School. He has advised state, federal and international governments around COVID-19 testing strategies.

John P. Moore, PhD — Professor of Microbiology and Immunology at Weill Cornell Medicine — has conducted research on HIV vaccines and virology for over 30 years. During the pandemic, he became familiar with SARS-CoV-2 in the same subject areas. He also had decades of experience countering disinformation about HIV/AIDS and, more recently, COVID-19.

Jennifer Nuzzo, DrPH— Associate Professor, John Hopkins Bloomberg School of Public Health and Senior Fellow for Global Health, Council on Foreign Relations— is an epidemiologist by training who has worked on pandemic preparedness for 20 years. She is joining the Brown School of Public Health in April 2022, where she’ll be leading the school’s pandemic efforts.

Paul Offit, MD — Director of the Vaccine Education Center at the Children's Hospital of Philadelphia — served as a member of the CDC’s Advisory Committee on Immunization Practice, is a current member of FDA’s Vaccine and Related Biological Products (VRBP) Advisory Committee, and is author of many books on vaccines including Bad Faith (2015).

Michael T. Osterholm PhD, MPH, — Regents Professor, McKnight Presidential Endowed Chair in Public Health, and Director, Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota — has served numerous roles in the US Government, including Special Advisor to the Secretary, Department of Health and Human Services (2001-2003), Science Envoy, Department of State (2017-2018) and a member of the Biden-Harris Transition COVID Advisory Board (2020-2021.) He is coauthor of two New York Times best-sellers: Living Terrors: What America Needs to Know to Survive the Coming Bioterrorist Catastrophe (2001) and Deadliest Enemy: Our War Against Killer Germs (2017.)

David Putrino, PhD
Director of Rehabilitation Innovation, Mt. Sinai Health System
Assistant Professor of Rehabilitation Medicine
Icahn School of Medicine at Mt Sinai

Vivian Riefberg, MBA — Professor of Practice at the University of Virginia Darden School of Business — has held a variety of senior leadership positions at McKinsey & Company including leader of the Americas Public Sector Practice and co-leader of the US Healthcare Practice.

E. John Wherry, PhD — Chair of the Department of Systems Pharmacology & Translational Therapeutics at the University of Pennsylvania — has 25 years of experience studying viral immunology, most recently focusing on immunity to SARS-CoV-2 following infection or vaccination.

CONTRIBUTORS/REVIEWERS

Joseph Allen, DSc, MPH
Deputy Director, Education and Research Center for Occupational Health and Safety
Director, Health Buildings Program
Associate Professor of Exposure Assessment Science
Harvard T.H. Chan School of Public Health

Kenneth Baer, DPhil
CEO and Founder, Crosscut Strategies
Former Associate Director at the Office of Management and Budget

Debbie Berkowitz
Practitioner Fellow
Kalmanovitz Initiative for Labor and the Working Poor
Georgetown University

Rear Admiral Kenneth Bernard MD, USPHS (Ret)
Council on Strategic Risks

John M. Bridgeland
Co-Founder and CEO, COVID Collaborative
Former Director, White House Domestic Policy Council

Rebecca Cokley
US Disability Rights Program Officer for the Ford Foundation
Former Executive Director of the National Council on Disability

Brent Colburn, MPP
Senior Vice President for External Relations and Communications
University of California
Brent Colburn previously served as the senior public affairs official at both the Department of Defense and the Department of Homeland Security and as the Director of External Affairs at FEMA.

Letitia Davis, ScD, EdM
Former Director of the Occupational Health Surveillance Program at the Massachusetts Department of Public Health (MDPH)

Gary Edson
President, COVID Collaborative
Former White House Deputy National Security Advisor & Deputy National Economic Advisor

Jeremy Samuel Faust, MD, MS
Emergency Medicine Physician, Brigham and Women’s Hospital Department of Emergency Medicine/Division of Health Policy and Public Health, Harvard Medical School

Julie Gerberding, MD, MPH
Chief Patient Officer and Executive Vice President Population Health & Sustainability, Merck
Former Director, U.S. Centers for Disease Control and Prevention (CDC)

Robert Harrison, MD, MPH
Clinical Professor of Medicine
Division of Occupational and Environmental Medicine
University of California, San Francisco

Kevin Hedges, PhD, CIH, COH
Board Member and Past President
Workplace Health Without Borders (International)

William R. Hite, Jr., EdD
Superintendent
School District of Philadelphia

David Holtgrave, PhD
Dean, SUNY Empire Innovation Professor, Distinguished Professor
School of Public Health
University at Albany, State University of New York
Dr. Holtgrave's three-decade career in public health has also included senior positions at the Centers for Disease Control and Prevention (CDC), Emory University Rollins School of Public Health, and Johns Hopkins Bloomberg School of Public Health; he also served as Vice-Chair of the Presidential Advisory Council on HIV/AIDS during President Obama's administration.

Jose L. Jimenez, PhD
Distinguished Professor of Chemistry & Fellow of CIRES
University of Colorado-Boulder

Kushal Kadakia, MSc
MD Candidate at Harvard Medical School

Bill Kojola
Industrial Hygienist, Retired

Linsey Marr, PhD
Charles P. Lunsford Professor
Virginia Polytechnic Institute and State University

Donald K Milton, MD, DrPH
MPowering Maryland Professor
Department of Environmental & Occupational Health
School of Public Health
University of Maryland

Thomas M. Peters, PhD, CIH
Professor and Interim Head
Occupational and Environmental Health
University of Iowa

Rebecca L. Reindel, MS, MPH
Safety and Health Director
AFL-CIO

Jonathan Rosen, MS CIH
AJ Rosen & Associates LLC

Peg Seminario
Past Director of Occupational Safety and Health
AFL-CIO

Jeffrey Siegel, PhD
Bahen/Tanenbaum Chair in Civil Engineering
Department of Civil and Mineral Engineering
University of Toronto

Margaret Sietsema, PhD, CIH
Assistant Professor
University of Illinois at Chicago

Thomas C. Smith
President and CEO
3Flow

Jelena Srebric, PhD
Director of Center for Sustainability in the Built Environment (City@UMD)
Margaret G. and Frederick H. Kohloss Chair Professor in Mechanical Engineering
University of Maryland

Gregory R. Wagner, MD
Department of Environmental Health
Harvard T.H. Chan School of Public Health